Baudax Bio, Inc. (BXRX:NASDAQ) rocketted at $4.17, representing a gain of 32.4%. On Tue, Jan 24, 2023, BXRX:NASDAQ hit a New 2-Week High of $4.17. The stock appeared on our News Catalysts scanner on Tue, Jan 24, 2023 at 08:12 AM in the 'BIOTECH' category. From Tue, Jan 10, 2023, the stock recorded 44.44% Up Days and 40.00% Green Days
The stock spiked on Tue, Jan 24, 2023 at $6.89 with a volume of 47M+.
About Baudax Bio, Inc. (BXRX:NASDAQ)
Baudax Bio Inc is a Pharmaceutical company. The company develops and commercialize products for hospital and related acute care settings.
Top 10 Gainers:
- bioAffinity Technologies Inc. (BIAF:NASDAQ), 74.38%
- Grom Social Enterprises Inc. (GROM:NASDAQ), 44.14%
- Axcella Health Inc. (AXLA:NASDAQ), 38.31%
- Baudax Bio, Inc. (BXRX:NASDAQ), 32.38%
- ContraFect Corporation (CFRX:NASDAQ), 31.24%
- Sotherly Hotels Inc. (SOHO:NASDAQ), 23.4%
- Bit Brother Limited (BTB:NASDAQ), 23.08%
- IronNet Inc. (IRNT:NYSE), 22.58%
- PyroGenesis (PYR:NASDAQ), 22.34%
- Vincerx Pharma Inc. (VINC:NASDAQ), 22.22%